Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Cited by (970)

Items 101–200 of 970

1. Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer
   Federica Cappellesso, Marie‐Pauline Orban, Niranjan Shirgaonkar, Emanuele Berardi, Jens Serneels, Marie-Aline C. Neveu, Daria Di Molfetta, Francesca Piccapane, Rosa Caroppo, Lucantonio Debellis et al. · 2022 · Nature Cancer
2. Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
   Yi Wang, Kai Conrad Cecil Johnson, Margaret Elena Gatti-Mays, Zihai Li · 2022 · Journal of Hematology & Oncology
3. Bispecific dendritic-T cell engager potentiates anti-tumor immunity
   Yuval Shapir Itai, Oren Barboy, Ran Salomon, Akhiad Bercovich, Ken Xie, Eitan E. Winter, Tamar Shami, Ziv Porat, Neta Erez, Amos Tanay et al. · 2024 · Cell
4. CD4+ T cells in antitumor immunity
   Elena I Montauti, David Yoonsuk Oh, Lawrence H. Fong · 2024 · Trends in cancer
5. Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients
   Alain Patrick Algazi, Shailender Bhatia, Sanjiv S. Agarwala, M. Molina, Karl D. Lewis, Mark B. Faries, Lawrence H. Fong, Lauren P. Levine, M. Franco, Arielle Oglesby et al. · 2020 · Annals of Oncology
6. NF-κB signaling pathway in tumor microenvironment
   Yaning Cao, Yanan Yi, Chongxu Han, Bingwei Shi · 2024 · Frontiers in Immunology
7. Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity
   Choi, Yongbin, Lichterman, Jake N., Coughlin, Laura A., Poulides, Nicole, Li, Wenling, Del Valle, Priscilla, Palmer, Suzette N., Gan, Shuheng, Kim, Jiwoong, Zhan, Xiaowei et al. · 2023 · Science Immunology
8. Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis
   Won, Taejoon, Kalinoski, Hannah M., Wood, Megan K., Hughes, David M., Jaime, Camille M., Delgado, Paul, Talor, Monica V., Lasrado, Ninaad, Reddy, Jay, Čiháková, Daniela · 2022 · Cell Reports
9. Immunology of IL-12: An update on functional activities and implications for disease
   Ullrich, Karen A.-M., Schulze, Lisa Lou, Paap, Eva-Maria, Müller, Tanja M., Neurath, Markus F., Zundler, Sebastian · 2020 · EXCLI journal
10. NF-κB–dependent IRF1 activation programs cDC1 dendritic cells to drive antitumor immunity
    Ghita Ghislat, Ammar Sabir Cheema, Elodie Baudoin, Christophe Verthuy, Pedro J. Ballester, Karine Crozat, Noudjoud Attaf, Chuang Dong, Pierre Milpied, Bernard MALISSEN et al. · 2021 · Science Immunology
11. Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
    Yash Agarwal, Lauren E. Milling, Jason Y.H. Chang, Luciano Santollani, Allison M. Sheen, Emi A. Lutz, Anthony Tabet, Jordan A. Stinson, Kaiyuan Ni, Kristen A. Rodrigues et al. · 2022 · Nature Biomedical Engineering
12. Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications
    Eleonora Aricò, Luciano Castiello, Imerio Capone, Lucia Gabriele, Filippo Belardelli · 2019 · Cancers
13. Engineering interferons and interleukins for cancer immunotherapy
    Patrick G. Holder, Shion An Lim, Christine Huang, Preeti Apurve Sharma, Yavuz S. Dagdas, Beyza Bulutoglu, Jonathan T. Sockolosky · 2022 · Advanced Drug Delivery Reviews
14. Lack of CD8 + T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer
    Brendan L. Horton, Duncan M. Morgan, Noor Momin, Maria Zagorulya, Elen Torres-Mejia, Vidit Bhandarkar, Karl Dane Wittrup, John Christopher Love, Stefani Spranger · 2021 · Science Immunology
15. A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion
    Seung Mo Jin, Yeon Jeong Yoo, Hong Sik Shin, Sohyun Kim, Sang Nam Lee, Chang Hoon Lee, Hyunji Kim, Jung‐Eun Kim, Yong‐Soo Bae, JungHyub Hong et al. · 2023 · Nature Nanotechnology
16. SENP3 senses oxidative stress to facilitate STING-dependent dendritic cell antitumor function
    Hu, Zhilin, Teng, Xiao-Lu, Zhang, Tianyu, Yu, Xiaoyan, Ding, Rui, Yi, Jing, Deng, Liufu, Wang, Zhengting, Zou, Qiang · 2021 · Molecular Cell
17. Tuning the Tumor Myeloid Microenvironment to Fight Cancer
    Nadine S. Jahchan, Adriana M. Mujal, Joshua L. Pollack, Mikhail Binnewies, Venkataraman Sriram, Leonard M. Reyno, Matthew F. Krummel · 2019 · Frontiers in Immunology
18. IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy
    Yingmei Luo, Ze Chen, Mingjian Sun, Baohong Li, Fan Pan, Ai-Qing Ma, Jianhong Liao, Ting Yin, Xiaofan Tang, Guojun Huang et al. · 2021 · Biomaterials
19. Rethinking immune checkpoint blockade: ‘Beyond the T cell’
    Xiuting Liu, Graham D. Hogg, David G. DeNardo · 2021 · Journal for ImmunoTherapy of Cancer
20. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
    Eleonora Ghisoni, Matteo Morotti, Apostolos Sarivalasis, Alizée J Grimm, Lana Elias Kandalaft, Denarda Dangaj Laniti, George Coukos · 2024 · Nature Reviews Clinical Oncology
21. Turning cold into hot: emerging strategies to fire up the tumor microenvironment
    Kaili Ma, Lin Wang, Wenhui Li, Tingting Tang, Bo Ma, Liyuan Zhang, Lianjun Zhang · 2024 · Trends in cancer
22. Hypoxia and the phenomenon of immune exclusion
    Pietrobon, Violena, Marincola, Francesco M. · 2021 · Journal of Translational Medicine
23. The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review
    Toufik Abdul‐Rahman, Shankhaneel Ghosh, Sarah M. Badar, Abubakar Nazir, Gafar Babatunde Bamigbade, Narjiss Aji, Poulami Roy, Hajar kachani, Neil K. Garg, Lukman Lawal et al. · 2024 · European journal of medical research
24. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes
    Chunmei Fu, Peng Peng, Jakob Loschko, Feng Li, Phuong Pham, Weiguo Cui, Kelvin P. Lee, Anne Krug, Aimin Jiang · 2020 · Proceedings of the National Academy of Sciences
25. In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue
    Zhi Li, Zewen Kelvin Tuong, Isaac Dean, Claire Willis, Fabrina Gaspal, Rémi Fiancette, Suaad Idris, Bethany C. Kennedy, John R. Ferdinand, Ana Peñalver et al. · 2022 · The Journal of Experimental Medicine
26. Amplified Cancer Immunotherapy of a Surface-Engineered Antigenic Microparticle Vaccine by Synergistically Modulating Tumor Microenvironment
    Hongjuan Zhao, Beibei Zhao, Lixia Wu, Huifang Xiao, Kaili Ding, Cuixia Zheng, Qingling Song, Lingling Sun, Lei Wang, Zhenzhong Zhang · 2019 · ACS Nano
27. Type 1 conventional dendritic cells maintain and guide the differentiation of precursors of exhausted T cells in distinct cellular niches
    Sabrina Dähling, Ana Maria Mansilla, Konrad Knöpper, Anika Grafen, Daniel T. Utzschneider, Milas Ugur, Paul G. Whitney, Annabell Bachem, Panagiota Arampatzi, Fabian Imdahl et al. · 2022 · Immunity
28. Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction
    Jingya Qiu, Bihui Xu, Darwin Ye, Diqiu Ren, Shangshang Wang, Joseph L. Benci, Yuanming Xu, Hemant Ishwaran, Jean‐Christophe Beltra, E. John Wherry et al. · 2023 · Nature Cancer
29. Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
    Zhangfeng Zhong, Chi Teng Vong, Feiyu Chen, Horyue Tan, Cheng Zhang, Ning Wang, Liao Cui, Yitao Wang, Yibin Feng · 2022 · Medicinal Research Reviews
30. Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines
    Jee Hye Kang, Jeffrey A. Bluestone, Arabella Young · 2021 · Trends in Immunology
31. Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
    Volker Schirrmacher, Stefaan Van Gool, Wilfried Stuecker · 2019 · Biomedicines
32. Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment
    David A. Wheeler, Naoko Takebe, Toshinori Hinoue, Katherine A. Hoadley, Maria Cardenas, Alina M. Hamilton, Peter W. Laird, Linghua Wang, Adrienne Johnson, Ninad Dewal et al. · 2020 · Cancer Cell
33. Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
    Laura Boyero, Amparo Sánchez-Gastaldo, Miriam D. Alonso, José Francisco Noguera-Uclés, Sonia Molina‐Pinelo, Reyes Bernabé · 2020 · Cancers
34. Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer
    Jing Chen, Hong-Wei Sun, Yanyan Yang, Haitian Chen, Xing-Juan Yu, Wenchao Wu, Yi-Tuo Xu, Li-Lian Jin, Xiaojun Wu, Jing Xu et al. · 2021 · Signal Transduction and Targeted Therapy
35. Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy
    Kim M. van Pul, Marieke F. Fransen, Rieneke van de Ven, Tanja D. de Gruijl · 2021 · Frontiers in Immunology
36. Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
    Nicholas C. DeVito, Michael P. Plebanek, Bala Theivanthiran, Brent Allen Hanks · 2019 · Frontiers in Immunology
37. Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
    Douglas Hanahan, Olivier Alain Michielin, Mikaël J. Pittet · 2024 · Nature reviews. Cancer
38. Circulating immune cell phenotype dynamics reflect the strength of tumor–immune cell interactions in patients during immunotherapy
    Jason I. Griffiths, Pierre Wallet, Lance T. Pflieger, David Dean Stenehjem, Xuan Liu, Patrick A. Cosgrove, Neena A. Leggett, Jasmine A. McQuerry, Gajendra Shrestha, Maura Maria Rossetti et al. · 2020 · Proceedings of the National Academy of Sciences
39. Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events
    Les, Iñigo, Martínez, Mireia, Pérez-Francisco, Inés, Cabero, María, Teijeira, Lucía, Arrazubi, Virginia, Torrego, Nuria, Campillo-Calatayud, Ana, Elejalde, Iñaki, Kochan, Grazyna et al. · 2023 · Cancers
40. Biomaterial‐Based In Situ Cancer Vaccines
    Bo Yang, Hua Wang · 2023 · Advanced Materials
41. Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC)
    Masanori Oshi, Stephanie Newman, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Paweł Kaliński, Itaru Endo, Kazuaki Takabe · 2020 · Cancers
42. HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
    Kwon‐Ho Song, Se Jin Oh, Suyeon Kim, Hanbyoul Cho, Hyo-Jung Lee, Joon Seon Song, Joon‐Yong Chung, Eunho Cho, Jaeyoon Lee, Seunghyun Jeon et al. · 2020 · Nature Communications
43. Molecular mechanisms of dendritic cell migration in immunity and cancer
    Charlotte M. de Winde, Clare Munday, Sophie E. Acton · 2020 · Medical Microbiology and Immunology
44. Biomimetic Anti‐PD‐1 Peptide‐Loaded 2D FePSe 3 Nanosheets for Efficient Photothermal and Enhanced Immune Therapy with Multimodal MR/PA/Thermal Imaging
    Xueyang Fang, Xianlin Wu, Zhendong Li, Lijun Jiang, Wai‐Sum Lo, Guanmao Chen, Yanjuan Gu, Wing‐Tak Wong · 2020 · Advanced Science
45. The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy
    Erin E Peterson, Kevin C. Barry · 2021 · Frontiers in Immunology
46. Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy
    Christopher B. Rodell, Maaz S. Ahmed, Christopher Garris, Mikaël J. Pittet, Ralph Weissleder · 2019 · Theranostics
47. Designing immunogenic nanotherapeutics for photothermal-triggered immunotherapy involving reprogramming immunosuppression and activating systemic antitumor responses
    Jing Wang, Yanzhou Chang, Hui Luo, Wenxiao Jiang, Ligeng Xu, Tianfeng Chen, Xueqiong Zhu · 2020 · Biomaterials
48. Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
    William W. Ho, Igor Lucas Gomes-Santos, Shuichi Aoki, Meenal Datta, Kosuke Kawaguchi, Nilesh P. Talele, Sylvie Roberge, Jun P. Ren, Hao Liu, Ivy X. Chen et al. · 2021 · Proceedings of the National Academy of Sciences
49. Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
    María Julia Lamberti, Annunziata Nigro, Fátima María Mentucci, Natalia Belén Rumie Vittar, Vincenzo Casolaro, Jessica Dal Col · 2020 · Pharmaceutics
50. The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy
    Jong‐Dae Lee, Beatriz Lozano‐Ruiz, Fengyuan Mandy Yang, Dengxia Denise Fan, Liya Shen, José Manuel González-Navajas · 2021 · Frontiers in Immunology
51. Checkpoint Inhibitor Pneumonitis Induced by Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer: Occurrence and Mechanism
    Jianqiong Yin, Yuanjun Wu, Xue Yang, Lu Gan, Jianxin Xue · 2022 · Frontiers in Immunology
52. Injectable Anti-inflammatory Nanofiber Hydrogel to Achieve Systemic Immunotherapy Post Local Administration
    Muchao Chen, Yanjun Tan, Ziliang Dong, Jiaqi Lu, Xiao Han, Qiutong Jin, Wenjun Zhu, Jingjing Shen, Liang Cheng, Zhuang Liu et al. · 2020 · Nano Letters
53. Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
    Luisa Chocarro, Miren Zuazo, Hugo Arasanz, Ana Bocanegra, Carlos Hernandez, Gonzalo Fernández, María Jesús García-Granda, Ester Blanco, Ruth Vera, Grazyna T. Kochan et al. · 2020 · Frontiers in Pharmacology
54. Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma
    Hyun-Jin Kim, Jang Hyun Park, Hyeon Cheol Kim, Chae Won Kim, In Kang, Heung Kyu Lee · 2022 · Nature Communications
55. Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies
    Wendi Kang, Zhichao Feng, Jianwei Luo, Zhenhu He, Jun Liu, Jianzhen Wu, Pengfei Rong · 2021 · Frontiers in Immunology
56. Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice
    Shilong Zhang, Bing Han, Yuqin Mao, Zhengyan Zhang, Zhanming Li, Chao‐Yue Kong, You Wu, Guoqiang Chen, Li‐Shun Wang · 2022 · Gut Microbes
57. PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade
    Marcel P. Trefny, Monika Kaiser, Michal A. Stanczak, Petra Herzig, Spasenija Savic, Mark Nikolaj Wiese, Didier Lardinois, Heinz Philipp Laubli, Franziska Uhlenbrock, Alfred Zippelius · 2020 · Cancer Immunology Immunotherapy
58. Mechanical checkpoint regulates monocyte differentiation in fibrotic niches
    Kyle H. Vining, Anna E. Marneth, Kwasi Adu‐Berchie, Joshua M. Grolman, Christina M. Tringides, Yutong Liu, Waihay J. Wong, Olga Pozdnyakova, Mariano Severgnini, Alexander G. Stafford et al. · 2022 · Nature Materials
59. Tumor immunogenicity dictates reliance on TCF1 in CD8+ T cells for response to immunotherapy
    Giulia Escobar, Katherine Tooley, Joan Pagès Oliveras, Linglin Huang, Hanning Cheng, Michelle L. Bookstaver, Camilla Edwards, Eugene Froimchuk, Chang Xue, Davide Mangani et al. · 2023 · Cancer Cell
60. Pharmacological Wnt Ligand Inhibition Overcomes Key Tumor-Mediated Resistance Pathways to Anti-PD-1 Immunotherapy
    Nicholas C. DeVito, Michael S. Sturdivant, Bala Thievanthiran, Christine Xiao, Michael P. Plebanek, April K.S. Salama, Georgia Marie Beasley, Alisha Holtzhausen, Veronica Novotny‐Diermayr, John H. Strickler et al. · 2020 · Cell Reports
61. Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy
    Marie R. Siwicki, Nicolas A. Gort-Freitas, Marius Messemaker, Ruben Bill, Jeremy Gungabeesoon, Camilla Engblom, Rapolas Žilionis, Christopher Garris, Genevieve M. Gerhard, Anna Kohl et al. · 2021 · Science Immunology
62. The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma—Recent Findings and Review
    Jędrzej Borowczak, Krzysztof Szczerbowski, Mateusz Maniewski, Adam Kowalewski, Marlena Janiczek-Polewska, Anna Szylberg, Andrzej Marszałek, Łukasz Szylberg · 2022 · Biomedicines
63. NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity
    Nicole Kirchhammer, Marcel P. Trefny, Marina Natoli, Dominik Brücher, Sheena N. Smith, Franziska Werner, Victoria Koch, David Schreiner, Ewelina Magdalena Bartoszek, Mélanie Buchi et al. · 2022 · Science Translational Medicine
64. Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds
    Haiyan Wang, Shasha Li, Qianyu Wang, Zhengshuo Jin, Wei Shao, Yan Gao, Lu Li, Kequan Lin, Lin Zhu, Huili Wang et al. · 2021 · Science Advances
65. Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis
    Molly Fisher Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep, Pritha Sen, Nandini Samanta, Jessica Tantivit, Mazen Nasrallah, Leyre Zubiri, Neal Patrick Smith, Alice J. Tirard et al. · 2024 · Nature Medicine
66. Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization
    Guolong Xu, Dongju Feng, Yao Yao, Peipei Li, Hua Sun, Hong Yang, Changxian Li, R Jiang, Beicheng Sun, Yun Chen · 2019 · Oncogene
67. Metal-Phenolic Vehicles Potentiate Cycle-Cascade Activation of Pyroptosis and cGAS-STING Pathway for Tumor Immunotherapy
    Weikai Sun, Hong Wang, Yafei Qi, Mengqi Li, Ruyue Zhang, Zhiliang Gao, Jiwei Cui, Dexin Yu · 2024 · ACS Nano
68. Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape
    Hicks, Kristin C., Chariou, Paul L., Ozawa, Yohei, Minnar, Christine M., Knudson, Karin M., Meyer, Thomas J., Bian, Jing, Cam, Margaret, Schlom, Jeffrey, Gameiro, Sofia R. · 2021 · Nature Communications
69. Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and α-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells
    Rein Verbeke, Ine Lentacker, Karine Breckpot, J. Janssens, Serge Van Calenbergh, Stefaan C. De Smedt, Heleen Dewitte · 2019 · ACS Nano
70. NF-κB in the New Era of Cancer Therapy.
    B. Eluard, C. Thieblemont, V. Baud · 2020 · Trends in Cancer
71. Interleukin-2 signals converge in a lymphoid–dendritic cell pathway that promotes anticancer immunity
    Miro E. Raeber, Rodney Alexander Rosalia, Dominic Schmid, Ufuk Karakus, Onur Boyman · 2020 · Science Translational Medicine
72. Whole tumour cell-based vaccines: tuning the instruments to orchestrate an optimal antitumour immune response
    Amarilis Pérez-Baños, María Alejandra Gleisner, Iván Flores, Cristián Pereda, Mariela Navarrete, Juan Pablo Araya, Giovanna Navarro, Claudia Quezada-Monrás, Andrés Tittarelli, Flavio Salazar‐Onfray · 2023 · British Journal of Cancer
73. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
    Jiangping Li, Zhiwen Xiao, Donghui Wang, Lei Jia, Shihong Nie, Xingda Zeng, Wei Hu · 2023 · Molecular Cancer
74. NF-κB in Cancer Immunity: Friend or Foe?
    Guilhem Lalle, Julie Twardowski, Yenkel Grinberg‐Bleyer · 2021 · Cells
75. Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity
    Madhav D. Sharma, Rafał Pacholczyk, Huidong Shi, Zuzana Berrong, Yousef Zakharia, Austin Greco, Chang-Sheng S. Chang, Sudharshan Eathiraj, Eugene Paul Kennedy, Thomas Cash et al. · 2021 · Immunity
76. Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
    Vidit Bhandarkar, Teresa Dinter, Stefani Spranger · 2025 · Science Immunology
77. Studying interactions between dendritic cells and T cells in vivo
    Aleksey Chudnovskiy, Giulia Pasqual, Gabriel D. Victora · 2019 · Current Opinion in Immunology
78. Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer
    Christopher Garris, Jeffrey L. Wong, Jeffrey V. Ravetch, David A. Knorr · 2021 · Science Translational Medicine
79. Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
    Adrià Archilla‐Ortega, Carla Domuro, Juan Martín-Liberal, Purificacı́on Muñoz · 2022 · Journal of Experimental & Clinical Cancer Research
80. Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting
    Ran Salomon, Hagar Rotem, Yonatan Katzenelenbogen, Assaf Weiner, Noy Cohen Saban, Tali Feferman, Ido Amit, Rony Dahan · 2022 · Nature Cancer
81. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
    Tracy C. Kuo, Amy Yen-Chi Chen, Ons Harrabi, Jonathan T. Sockolosky, Anli Zhang, Emma Sangalang, Laura V. Doyle, Steven E. Kauder, Danielle A. Fontaine, Sangeetha Subbarao Bollini et al. · 2020 · Journal of Hematology & Oncology
82. The strategies to cure cancer patients by eradicating cancer stem-like cells
    Yansui Mai, Jiyan Su, Chuan Yang, Chenglai Xia, Liwu Fu · 2023 · Molecular Cancer
83. Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy
    Christine Moussion, Lélia Delamarre · 2023 · Seminars in Immunology
84. A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy
    Diwei Zheng, Fan Gao, Cheng Qian, Peng Bao, Xue Dong, Jin‐Xuan Fan, Wen Long Song, Xuan Zeng, Si‐Xue Cheng, Xian‐Zheng Zhang · 2020 · Nature Communications
85. The evolutionary legacy of immune checkpoint inhibitors
    Kaushik, Itishree, Ramachandran, Sharavan, Zabel, Carson, Gaikwad, Shreyas, Srivastava, Sanjay K. · 2022 · Seminars in Cancer Biology
86. The CAR T‐Cell Mechanoimmunology at a Glance
    Rui Li, Chao Ma, Haogang Cai, Weiqiang Chen · 2020 · Advanced Science
87. WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway
    Ensong Guo, Rourou Xiao, Yifan Wu, Funian Lu, Chen Liu, Bin Yang, Xi Li, Yu Fu, Zizhuo Wang, Li Yuan et al. · 2021 · The Journal of Experimental Medicine
88. Allies or Enemies—The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment
    Lisa Haas, Anna C. Obenauf · 2019 · Frontiers in Immunology
89. CD8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy
    Biao Zhang, Jinming Liu, Yuying Mo, Kexin Zhang, Bingqian Huang, Dong Shang · 2024 · Frontiers in Immunology
90. The Paradox of Cancer Immune Exclusion: Immune Oncology Next Frontier
    Sara Isabel Pai, Alessandra Cesano, Francesco Maria Marincola · 2020 · Cancer treatment and research
91. Boiling histotripsy and in-situ CD40 stimulation improve the checkpoint blockade therapy of poorly immunogenic tumors
    Mohit Pratap Singh, Sri Nandhini Sethuraman, Craig Miller, Jerry R. Malayer, Ashish Ranjan · 2020 · Theranostics
92. Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
    Colin Y.C. Lee, Bethany C. Kennedy, Nathan Richoz, Isaac Dean, Zewen Kelvin Tuong, Fabrina Gaspal, Zhi Li, Claire Willis, Tetsuo Hasegawa, Sarah K. Whiteside et al. · 2024 · Nature Communications
93. Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
    Iva Truxová, David Cibula, Radek Špíšek, Jitka Palich Fucikova · 2023 · Journal for ImmunoTherapy of Cancer
94. Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy
    Sjoerd T. T. Schetters, Ernesto Rodríguez, Laura J. W. Kruijssen, Matheus H. W. Crommentuijn, Louis Boon, Jan Van den Bossche, Joke M. M. den Haan, Yvette van Kooyk · 2020 · Journal for ImmunoTherapy of Cancer
95. The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors
    Zhaozhen Wu, Pengfei Cui, Haitao Tao, Sujie Zhang, Junxun Ma, Zhefeng Liu, Jinliang Wang, Yuanyu Qian, Shixue Chen, Ziwei Huang et al. · 2021 · Clinical Medicine Insights Oncology
96. Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota
    Arthur Edward Frankel, Sachin Kumar Deshmukh, Amit Reddy, Johnny Lightcap, Maureen Hayes, Steven B McClellan, Seema Singh, Brooks D. Rabideau, T. Grant Glover, Bruce Roberts et al. · 2019 · Integrative Cancer Therapies
97. Double-edged effects of interferons on the regulation of cancer-immunity cycle
    Xiao Zhang, Song Wang, Yuanyuan Zhu, Minghui Zhang, Yan Zhao, Zhengbin Yan, Qiuxu Wang, Xiaobo Li · 2021 · OncoImmunology
98. Dilemma and Challenge of Immunotherapy for Pancreatic Cancer
    Jia Wu, Jianting Cai · 2020 · Digestive Diseases and Sciences
99. Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma
    Chong Wu, Jie Lin, Yulan Weng, Dan-Ni Zeng, Jing Xu, Shufeng Luo, Li Xu, Mingyu Liu, Qiaomin Hua, Chaoqun Liu et al. · 2020 · Journal of Clinical Investigation
100. Particle radiotherapy in the era of radioimmunotherapy
     Zihan Zhou, Bingjie Guan, Huang Xia, Rong Zheng, Benhua Xu · 2023 · Cancer Letters